Innoprot

Innoprot provides products and technologies for multiplexing cell-based assays in drug discovery and development. 
With a proprietary technology for GPCR screening, Innoprot is able to perform functional assays, analyzing simultaneously both GPCR activation pathways in living cells; G-Protein pathway by Calcium, cAMP, DAG or RhoGTP and b-arrestin recruitment. 
Innoprot also acts as a C.R.O. providing screening services focused on GPCRs, Fibrosis and Neurodegenerative diseases such as Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis.